Oh Kibong, Hwang Shin, Ahn Chul-Soo, Kim Ki-Hun, Moon Deok-Bog, Ha Tae-Yong, Song Gi-Won, Jung Dong-Hwan, Hong Seung-Mo
Department of Surgery, Anyang SAM Hospital, Anyang, Korea.
Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Ann Hepatobiliary Pancreat Surg. 2021 Feb 28;25(1):34-38. doi: 10.14701/ahbps.2021.25.1.34.
BACKGROUNDS/AIMS: Hepatic inflammatory pseudotumor (HIPT) is a rare disease characterized by chronic infiltration of inflammatory cells and area of fibrosis. The objective of this retrospective observational study was to investigate clinicopathological features and outcomes of patients who underwent hepatic resection (HR) for HIPT.
From 2009 to 2018, seven patients with HIPT underwent HR, accounting for 0.06% of 11,979 adults who underwent HR at our center.
These seven patients included five men and two women. Their mean age was 62.3±11.6 years. In four patients with hepatitis B virus (HBV)-associated liver cirrhosis or chronic hepatitis, liver masses were suspected of hepatocellular carcinoma (HCC) or combined HCC-cholangiocarcinoma based on imaging studies. In three patients without HBV infection, two patients were suspected of HCC, for whom liver biopsy was not performed. One patient was suspected of liver abscess or HIPT, for whom percutaneous liver biopsy was performed and the mass was diagnosed with HIPT. However, this patient underwent HR owing to abdominal pain. No patient presented with abnormally elevated levels of alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, or CA19-9. During a mean follow-up period of 76.4±34.8 months, no patient experienced recurrence of HIPT.
HIPT, a rare form of liver disease, is often misdiagnosed as malignant liver tumor. Active histological diagnosis is warranted for patients with suspected HIPT to avoid unnecessary operation. HR can be indicated in case of diagnostic ambiguity of HIPT or under a clinical diagnosis of malignant liver tumor.
背景/目的:肝脏炎性假瘤(HIPT)是一种罕见疾病,其特征为炎性细胞的慢性浸润和纤维化区域。本回顾性观察性研究的目的是调查接受肝脏切除术(HR)治疗HIPT患者的临床病理特征及预后。
2009年至2018年,7例HIPT患者接受了HR,占在本中心接受HR的11979例成人患者的0.06%。
这7例患者包括5名男性和2名女性。他们的平均年龄为62.3±11.6岁。在4例患有乙型肝炎病毒(HBV)相关肝硬化或慢性肝炎的患者中,根据影像学检查,肝脏肿块被怀疑为肝细胞癌(HCC)或合并HCC-胆管癌。在3例无HBV感染的患者中,2例被怀疑为HCC,未进行肝脏活检。1例被怀疑为肝脓肿或HIPT,进行了经皮肝活检,肿块被诊断为HIPT。然而,该患者因腹痛接受了HR。没有患者出现甲胎蛋白、维生素K缺乏或拮抗剂-II诱导的蛋白或CA19-9水平异常升高。在平均76.4±34.8个月的随访期内,没有患者出现HIPT复发。
HIPT是一种罕见的肝脏疾病形式,常被误诊为恶性肝脏肿瘤。对于疑似HIPT的患者,有必要进行积极的组织学诊断以避免不必要的手术。在HIPT诊断不明确或临床诊断为恶性肝脏肿瘤的情况下,可以考虑进行HR。